In the present study, we report the immunometric measurement of endogenous vasoinhibin in the serum of pregnant women without and with preeclampsia using a novel enzyme-linked immunosorbent assay (ELISA) with an anti-vasoinhibin monoclonal antibody (vi-mab), which shows no cross-reactivity with PRL. This evidence concerns the gene PRL and preeclampsia.